These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36440764)

  • 1. Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure.
    Branca L; Tomasoni D; Cimino G; Cersosimo A; Lombardi CM; Chizzola G; Metra M; Adamo M
    J Cardiovasc Med (Hagerstown); 2023 Jan; 24(1):12-19. PubMed ID: 36440764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry.
    Vij V; Piayda K; Nelles D; Gloekler S; Galea R; Fürholz M; Meier B; Valgimigli M; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Sondergaard L; Nombela-Franco L; McInerney A; Korsholm K; Nielsen-Kudsk JE; Afzal S; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Saw J; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Ognerubov D; Merkulov E; Cruz-González I; Gonzalez-Ferreiro R; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Rodes-Cabau J; Sievert H; Nickenig G; Sedaghat A
    Clin Res Cardiol; 2022 Nov; 111(11):1276-1285. PubMed ID: 35849156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
    Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
    J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry.
    Sedaghat A; Vij V; Al-Kassou B; Gloekler S; Galea R; Fürholz M; Meier B; Valgimigli M; O'Hara G; Arzamendi D; Agudelo V; Asmarats L; Freixa X; Flores-Umanzor E; De Backer O; Søndergaard L; Nombela-Franco L; McInerney A; Korsholm K; Nielsen-Kudsk JE; Afzal S; Zeus T; Operhalski F; Schmidt B; Montalescot G; Guedeney P; Iriart X; Miton N; Saw J; Gilhofer T; Fauchier L; Veliqi E; Meincke F; Petri N; Nordbeck P; Rycerz S; Ognerubov D; Merkulov E; Cruz-González I; Gonzalez-Ferreiro R; Bhatt DL; Laricchia A; Mangieri A; Omran H; Schrickel JW; Rodes-Cabau J; Nickenig G
    Circ Cardiovasc Interv; 2021 May; 14(5):e010195. PubMed ID: 34003661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure.
    Chen Y; Zhang Y; Qu L; Huang W; Su X; Chen Y
    J Thromb Thrombolysis; 2021 Oct; 52(3):872-879. PubMed ID: 33666825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device.
    Luani B; Genz C; Herold J; Mitrasch A; Mitusch J; Wiemer M; Schmeißer A; Braun-Dullaeus RC; Rauwolf T
    BMC Cardiovasc Disord; 2019 May; 19(1):112. PubMed ID: 31092201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of thrombus formation after percutaneous left atrial appendage closure using the WATCHMAN device.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Heart Vessels; 2017 Sep; 32(9):1137-1143. PubMed ID: 28477098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why Follow-up Examinations After Left Atrial Appendage Closure Are Important: Detection of Complications During Follow-up and How to Deal with Them.
    Wunderlich NC; Lorch GC; Honold J; Franke J; Küx H
    Curr Cardiol Rep; 2020 Aug; 22(10):113. PubMed ID: 32770393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial).
    Main ML; Fan D; Reddy VY; Holmes DR; Gordon NT; Coggins TR; House JA; Liao L; Rabineau D; Latus GG; Huber KC; Sievert H; Wright RF; Doshi SK; Douglas PS
    Am J Cardiol; 2016 Apr; 117(7):1127-34. PubMed ID: 26993976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
    J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of incomplete device endothelialization after left atrial appendage closure.
    Xu J; Chen CZ; Xing J; Wang L; Tao YR; Yang B; Zhang Q; Shen YL; Hu JQ
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):451-459. PubMed ID: 36136204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
    Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.